课题基金 / 基金详情

IMMUNOREGULATORY CIRCUITS IN MAN

IMMUNOREGULATORY CIRCUITS IN MAN
人类的免疫调节回路
批准号:
6511672
负责人:
Chikao Morimoto
金额:
$27.44万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 2004-06-30

项目摘要

项目成果

Chikao Morimoto的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自研究者的摘要):记忆CD4 t细胞发挥作用
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): Memory CD4 T-cells play a key role in host defense as well as the triggering and maintaining of inflammation. The triggering of the costimulatory signals plays a central role in the generation of effective immune responses. The costimulatory signals can be provided by a number of accessory molecules. Of the costimulatory molecules, CD29/VLA, CD26, and CD27 have been established by this group. CD29/VLA and CD26 are preferentially expressed on CD4 memory T-cells and play an important role in the costimulation, function, and migration of memory T-cells. Much remains to be clarified regarding the complex functions of CD29/VLA and CD26 in signal transduction and the subsequent effects upon T-cell function and cell migration. The major goal of this application is to determine the immunoregulatory circuits in man. The specific aims of this application are: 1) The molecular basis of CD29/VLA in T-cell costimulation, signaling and T-cell function. They will define the structural basis of Cas-L tyrosine phosphorylation and FAK activation and define the role of Cas-L in CD29/VLA-mediated cytokine production and gene expression. Moreover, the role of Cas-L in T-cell migration will be defined. 2) The molecular basis of CD26/DPPIV in T-cell function and costimulation. The role of CD26/DPPIV in T-cell migration, the precise characteristics of the binding of ADA to CD26, and the functional significance of ADA in T-cell activation will be defined. In addition, the structure and function of the ligand of CD26 other than ADA will be defined. 3), The molecular and cellular defects in patients with autoimmune diseases. Analysis of VLA-mediated costimulation in patients with autoimmune diseases will be performed. Moreover, the expression and function, of Cas-L, and FAK as well as the migratory activity of T-cells in autoimmune diseases will be determined. In addition, the level of CD26/DPPIV in serum/plasma and its correlation with clinical complications in autoimmune diseases will be defined. The study will not only provide new insights into understanding of the mechanisms of T-cell activation and migration, but will also provide new insights into understanding the precise molecular mechanisms of immune abnormalities found in various autoimmune diseases and will lead to the development of rational therapy for the manipulation of the abnormalities found in such diseases.
期刊论文(92)
专著(0)
科研奖励(0)
会议论文
Human CD4/CD45RA+ and CD4/CD45RA- T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates.
人CD4/CD45RA和CD4/CD45RA-T细胞亚群表达CD4-p56lck复合物、CD4相关脂质激酶、TCR/CD3-p59fyn复合物,并且具有相似的酪氨酸激酶底物。
DOI: 10.1093/intimm/5.4.409
发表时间: 1993
期刊: International immunology
影响因子: 4.4
作者: [Rothstein,DM, daSilva,A, Sugita,K, Yamamoto,M, Prasad,KV, Morimoto,C, Schlossman,SF, Rudd,CE]
通讯作者: Rudd,CE
Cas-L is required for beta 1 integrin-mediated costimulation in human Tcells.
Cas-L 是人类 T 细胞中 β1 整合素介导的共刺激所必需的。
DOI: --
发表时间: 1999
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Kamiguchi,K, Tachibana,K, Iwata,S, Ohashi,Y, Morimoto,C]
通讯作者: Morimoto,C
DOI: 10.4049/jimmunol.159.6.2652
发表时间: 1997-09
期刊: Journal of immunology
影响因子: 4.4
作者: [S. Jacquot;T. Kobata;S. Iwata;C. Morimoto;S. Schlossman]
通讯作者: S. Jacquot;T. Kobata;S. Iwata;C. Morimoto;S. Schlossman
Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.
VLA/CD29分子的交联与抗CD3对无血清培养系统中CD4细胞的活化具有共同有丝分裂作用。
DOI: 10.1002/eji.1830210212
发表时间: 1991
期刊: European journal of immunology
影响因子: 5.4
作者: [Yamada,A, Nojima,Y, Sugita,K, Dang,NH, Schlossman,SF, Morimoto,C]
通讯作者: Morimoto,C
62
    CHARACTERIZATION OF IMMUNOREGULATORY T CELLS POST ALLOGENIC BMT
    • 批准号:
      6099462
    • 项目类别:
    • 资助金额:
      $18.9万
    • 财政年份:
      1998
    • 负责人:
      Chikao Morimoto
    • 依托单位:
    CHARACTERIZATION OF IMMUNOREGULATORY T CELLS POST ALLOGENIC BMT
    • 批准号:
      6234962
    • 项目类别:
    • 资助金额:
      $18.24万
    • 财政年份:
      1997
    • 负责人:
      Chikao Morimoto
    • 依托单位:
    STRUCTURE AND FUNCTION OF THE HUMAN DPPIV/CD26 MOLECULE
    • 批准号:
      2096730
    • 项目类别:
    • 资助金额:
      $14.62万
    • 财政年份:
      1993
    • 负责人:
      Chikao Morimoto
    • 依托单位:
    STRUCTURE AND FUNCTION OF THE HUMAN DPPIV/CD26 MOLECULE
    • 批准号:
      3200109
    • 项目类别:
    • 资助金额:
      $15.4万
    • 财政年份:
      1993
    • 负责人:
      Chikao Morimoto
    • 依托单位:
    海外基金